Delivery Order SPE2DB22D3401-SPE2DB25FT2DD
Award Date
2/19/25
Potential Completion Date
2/20/25
Potential Value
$2.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Telmisartan 80 mg tablets, a medication used to treat high blood pressure. The delivery order, valued at $2,676.04, has a firm fixed price and an ultimate completion date of June 5, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant...
This is a $3,510.34 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Telmisartan 80 mg tablets, a medication used to treat high blood pressure. The contract has an ultimate completion date of May 28, 2024 and was awarded on May 24, 2023. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,223.72 firm fixed-price contract is for the delivery of Telmisartan 80 mg tablets, a medication used to treat high blood pressure. The award has an ultimate completion date of December 10, 2024 and was not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,596.71 firm fixed-price contract is for the delivery of Telmisartan 80 mg tablets, a medication used to treat high blood pressure. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The $1,707.94 firm fixed-price contract is for the supply of Telmisartan 80 mg tablets, a medication used to treat high blood pressure. The delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a comprehensive range of...
This federal contract award, valued at $1,275.43, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Telmisartan 80 mg tablets, a medication used to treat high blood pressure and heart failure. The award is a Delivery Order under an existing Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,983.88 firm fixed-price contract is for the delivery of Telmisartan 80 mg tablets, a medication used to treat high blood pressure. The contract is not designated as a set-aside and represents a standard open competition award. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $13,142.31, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Telmisartan 80 mg Tablets in 30s, a medication used to treat high blood pressure and heart failure. The contract is a Firm Fixed Price Delivery Order with a completion date of November 26, 2024. This award is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,110.40 Firm Fixed Price delivery order is for Telmisartan 80 mg tablets, a medication used to treat high blood pressure and heart failure. The contract has an ultimate completion date of August 15, 2023 and was awarded on August 14, 2023. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp...
This federal contract award, with a ceiling value of $2,511.36, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the provision of Telmisartan 80 mg tablets, a medication used to treat high blood pressure. The contract has an ultimate completion date of June 26, 2024 and is a Firm Fixed Price arrangement. This contract is not designated as a set-aside....